Study # SourSop
A Pilot Study of Soursop Tea in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
A Pilot Study of Soursop Tea in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
Meta
Study Status:
Enrolling
Treatment Agent:
Soursop tea
Description
Short Title: Soursop
The study will determine if there is a reduction in malignant cell burden when patients with relapsed and/or refractory acute myeloid leukemia (AML) or multiple myeloma (MM) consume tea made from the dried leaves of Annona muricata (Soursop). The study goal is to determine the safety and anti-neoplastic efficacy of Annona muricata tea when taken in escalating frequency over a period of 21 days by patients with relapsed/refractory AML or MM for whom there are no standard therapeutic options.
Resources and Links
National Clinical Trial Identified Number: Not available at this time